Infinity To Present At BIO CEO & Investor Conference

Monday, February 5, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

CAMBRIDGE, Mass., Feb. 5, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene

Perkins, Infinity Pharmaceutical's chief executive officer, will present at the BIO CEO & Investor Conference on Monday, February 12, 2018, at 11:00 a.m. EST at The New York Marriott
in New York, NY. A live webcast of the presentation will be available on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.

About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:Stephanie Ascher, Stern Investor Relations, Inc. 212-362-1200 or Stephanie@sternir.com

 

Cision View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-bio-ceo--investor-conference-300590611.html

SOURCE Infinity Pharmaceuticals, Inc.

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store